Aziyo Biologics Announces Launch of OsteGro® V

Expands Regenerative Medicine Product Portfolio and Leverages Proprietary Processing Platform to Protect and Preserve Native Bone Cells Silver Spring, Md. – June 29, 2020 – Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage, regenerative medicine company creating the...
External links are provided for informational purposes only.
Aziyo bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.